Abstract
There is an increasing demand for the generation of recombinant pharmaceutical proteins for a wide array of therapeutic applications. In comparison to bacterial, yeast and animal cells, the production of recombinant proteins in plants with economic and therapeutic importance has only started recently. The most important prerequisite of any expression systems is that it should be simple and inexpensive. In this regard, plant-based expression has emerged an as accepted alternative to conventional expression platforms due to economic feasibility, rapid scalability, higher stability of recombinant proteins, safety due to lack of harmful substances (human, animal pathogens and pyrogens) and capability of producing proteins with desired secondary modifications. Heterologous expression using plants has played a pivotal role in the development of a myriad of recombinant proteins, including neutraceuticals and monoclonal antibodies being utilized in various therapeutic approaches. This paper presents an overview about the current status, various strategies and advantages of pharmaceutical protein production in plant expression systems. We also present a summary of expression of therapeutic monoclonal antibodies, vaccines, clinical trials and the regulatory aspects of plant-based expression. Furthermore, the challenges encountered in plant expression such as costs associated with existing purification strategies are discussed.
This is a preview of subscription content, access via your institution.
Abbreviations
- AAD:
-
Antibiotic-associated diarrhea
- Mab:
-
Monoclonal antibody
- ScFv:
-
Single chain variable fragment
- PMP:
-
Plant-made pharmaceuticals
References
Altman A, Hasegawa PM (2011) Plant biotechnology and agriculture: prospects for the 21st century. Academic Press, London
Aviezer D, Brill-Almon E, Shaaltiel Y, Hashmueli S, Bartfeld D, Mizrachi S, Liberman Y, Freeman A, Zimran A, Galun E (2009) A plant-derived recombinant human glucocerebrosidase enzyme—a preclinical and phase I investigation. PLoS One 4:e4792
Bartlett JG, Snape JW, Harwood WA (2009) Intron-mediated enhancement as a method for increasing transgene expression levels in barley. Plant Biotechnol J 7:856–866
Bock R (2015) Engineering plastid genomes: methods, tools, and applications in basic research and biotechnology. Ann Rev Plant Biol 66:211–241
Bosch D, Castilho A, Loos A, Schots A, Steinkellner H (2013) N-Glycosylation of plant-produced recombinant proteins. Curr Pharm Des 19:5503–5512
Broz A, Huang N, Unruh G (2013) Plant-based protein biomanufacturing. Genet Eng Biotechnol News 33:4
Chen R (2012) Bacterial expression systems for recombinant protein production: E. coli and beyond. Biotechnol Adv 30:1102–1107
Chen Q, Lai H (2014) Gene delivery into plant cells for recombinant protein production. Biomed Res Int 2014:932161
Chen Q, Santi L, Zhang C (2014) Plant made biologics. Biomed Res Int. doi:10.1155/2014/418064
Chiaiese P, Palomba F, Tatino F, Lanzillo C, Pinto G, Pollio A, Filippone E (2011) Engineered tobacco and microalgae secreting the fungal laccase POXA1b reduce phenol content in olive oil mill wastewater. Enzyme Microb Technol 49:540–546
Chung ND, Kim NS, Giap doV, Jang SH, Oh SM, Jang SH, Kim TG, Jang YS, Yang MS (2014) Production of functional human vascular endothelial growth factor (165) in transgenic rice cell suspension cultures. Enzyme Microb Technol 63:58–63
Cummings JF, Guerrero ML, Moon JE, Waterman P, Nielsen RK, Jefferson S, Gross FL, Hancock K, Katz JM, Yusibov V (2014) Safety and immunogenicity of a plant produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: a phase 1 dose-escalation study in healthy adults. Vaccine 32:2251–2259
Decker EL, Parsons J, Reski R (2014) Glyco-engineering for biopharmaceutical production in moss bioreactors. Front Plant Sci 5:346
Desai PN, Shrivastava N, Padh H (2010) Production of heterologous proteins in plants. Strategies for optimal expression. Biotechnol Adv 28:427–435
Dirisala VR, Jeevan A, Bix G, Yoshimura T, McMurray DN (2012) Molecular cloning and expression of the IL-10 gene from guinea pigs. Gene 498:120–127
Dirisala VR, Jeevan A, Ramasamy SK, McMurray DN (2013) Molecular cloning, expression and in silico structural analysis of guinea pig IL-17. Mol Biotechnol 55:277–287
Dirisala VR, Jeevan A, Ly LH, McMurray DN (2015) Molecular and biochemical characterization of recombinant guinea pig tumor necrosis factor-alpha (TNF-α). Mediat Inflamm (article ID 619480)
Dolleweerd CJV, Teh AYH, Banyard AC et al (2014) Engineering, expression in transgenic plants and characterization of E559, a rabies virus-neutralizing monoclonal antibody. J Infect Dis 210:200–208
Dugdale B, Mortimer CL, Kato M, James TA, Harding RM, Dale JL (2013) In plant activation: an inducible, hyperexpression platform for recombinant protein production in plants. Plant Cell 25:2429–2443
Egan AN, Schlueter J, Spooner DM (2012) Applications of next-generation sequencing in plant biology. Am J Bot 99:175–185
Egelkrout E, Rajan V, Howard JA (2012) Overproduction of recombinant proteins in plants. Plant Sci 184:83–101
Feller T, Pascal T, Koch N, Spiegel H, Addai-Mensah Fischer R et al (2013) Plant based production of recombinant plasmodium surface protein Pf38 and evaluation of its potential as a vaccine candidate. PLoS One 8:e79920
Ferreira AM, Gentile P, Chiono V, Ciardelli G (2012) Collagen for bone tissue regeneration. Acta Biomater 8:3191–3200
Fischer R, Schillberg S, Hellwig S, Twyman RM, Drossard J (2012) GMP issues for recombinant plant-derived pharmaceutical proteins. Biotechnol Adv 30:434–439
Fischer R, Schillberg S, Buyel JF, Twyman RM (2013) Commercial aspects of pharmaceutical protein production in plants. Curr Pharm Des 19:5471–5477
Fox JL (2003) Puzzling industry response to ProdiGene fiasco. Nat Biotechnol 21:3–4
Fujiwara Y, Aiki Y, Yang L, Takaiwa F, Kosaka A, Tsuji NM, Shiraki K, Sekikawa K (2010) Extraction and purification of human interleukin-10 from transgenic rice seeds. Protein Expr Purif 72:125–130
Gecchele E, Merlin M, Brozzetti A, Falorni A, Pezzotti M, Avesani L (2015) A comparative analysis of recombinant protein expression in different biofactories: bacteria, insect cells and plant systems. J Vis Exp 97:e52459–e52459
Gelse K, Pöschl E, Aigner T (2003) Collagens—structure, function, and biosynthesis. Adv Drug Deliv Rev 55:1531–1546
Gleba A, Giritch YY (2011) Plant viral vectors for protein expression. Horizon Scientific Press, London
Gleba YY, Tuse D, Giritch A (2014) Plant viral vectors for delivery by Agrobacterium. Plant viral vectors book. Springer, Berlin, pp 155–192
Hassouneh W, MacEwan SR, Chilkoti A (2012) Fusions of elastin-like polypeptides to pharmaceutical proteins. Methods Enzymol 502:215–237
Hefferon K (2013) Plant-derived pharmaceuticals for the developing world. Biotechnol J 8:1193–1202
Hiatt A, Cafferkey R, Bowdish K (1989) Production of antibodies in transgenic plants. Nature 342:76–78
Howard JA, Hood EE (2014) Commercial plant-produced recombinant protein products: case studies. Springer, New York
Hull AK, Criscuolo CJ, Mett V, Groen H, Steeman W, Westra H, Chapman G, Legutki B, Baillie L, Yusibov V (2005) Human-derived, plant-produced monoclonal antibody for the treatment of anthrax. Vaccine 23:2082–2086
Jain A, Saini V, Kohli DV (2013) Edible transgenic plant vaccines for different diseases. Curr Pharm Biotechnol 14:594–614
Jansen PLM, Bruijne JD (2012) Controlled-release interferon alpha 2b, a new member of the interferon family for the treatment of chronic hepatitis C. Expert Opin Investig Drugs 21:111–118
Jez J, Castilho A, Grass J, Vorauer-Uhl K, Sterovsky T, Altmann F, Steinkellner H (2013) Expression of functionally active sialylated human erythropoietin in plants. Biotechnol J 8:371–382
Kaldis A, Ahmad A, Reid A, McGarvey B, Brandle J, Ma S, Jevnikar A, Kohalmi SE, Menassa R (2013) High-level production of human interleukin-10 fusions in tobacco cell suspension cultures. Plant Biotechnol J 11:535–545
Kim H, Jeon J, Lee KJ, Ko K (2014) N-Glycosylation modification of plant-derived virus-like particles: an application in vaccine. Biomed Res Int (article ID 249519)
Kittur FS, Hung CY, Darlington DE, Sane DC, Xie J (2012) N-Glycosylation engineering of tobacco plants to produce asialoerythropoietin. Plant Cell Rep 31:1233–1243
Klimyuk V, Pogue G, Herz S, Butler J, Haydon H (2014) Production of recombinant antigens and antibodies in Nicotiana benthamiana using magnifection technology: GMP-compliant facilities for small- and large-scale manufacturing. Curr Top Microbiol Immunol 375:127–154
Komarnytsky S, Borisjuk NV, Borisjuk LG, Alam MZ, Raskin I (2000) Production of recombinant proteins in tobacco guttation fluid. Plant Physiol 124:927–934
Kwon KC, Verma D, Singh ND, Herzog R, Daniell H (2013) Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells. Adv Drug Deliv Rev 65:782–799
Lahrtz F (2015) How to successfully patent therapeutic antibodies. J Biomol Screen 20:484–491
Lai H, Engle M, Fuchs A et al (2010) Monoclonal antibodies produced in plants efficiently treats west Nile virus infection in mice. Proc Natl Acad Sci USA 9:2419–2424
Lee JH, Park DY, Lee KJ et al (2013) Intracellular Reprogramming of expression, glycosylation, and function of a plant-derived antiviral therapeutic monoclonal antibody. PLoS One 8:e68772
Leuzinger K, Dent M, Hurtado J et al (2013) Efficient agroinfiltration of plants for high-level transient expression of recombinant proteins. J Vis Exp 77:e5052
Li WL, Li K, Li J, Lin X, Sun X, Tang K (2011) Expression of biologically active human insulin-like growth factor 1 in Arabidopsis thaliana seeds via oleosin fusion technology. Biotechnol Appl Biochem 58:139–146
Luchakivskaya Y, Kishchenko O, Gerasymenko I, Olevinskaya Z, Simonenko Y, Spivak M, Kuchuk M (2011) High-level expression of human interferon alpha-2b in transgenic carrot (Daucus carota L.) plants. Plant Cell Rep 30:407–415
Makhzoum A, Benyammi R, Moustafa K, Trémouillaux-Guiller J (2013) Recent advances in host plants and expression cassettes structure and function in plant molecular pharming. Biodrugs 28:145–159
Makvandi-Nejad S, McLean MD, Hirama T, Almquist KC, MacKenzie CR, Hall JC (2005) Transgenic tobacco plants expressing a dimeric single-chain variable fragment (scFv) antibody against Salmonella enterica serotype Paratyphi B. Transgenic Res 14:785–792
Maxmen A (2012) Drug-making plant blooms. Nature 485:160
Merlin M, Gecchele E, Capaldi S, Pezzotti M, Avesani L (2014) Comparative evaluation of recombinant protein production in different biofactories: the green perspective. Biomed Res Int (article ID 136419)
Mortimer E, Maclean JM, Mbewana S, Buys A, Williamson AL, Hitzeroth II, Rybicki EP (2012) Setting up a platform for plant-based influenza virus vaccine production in South Africa. BMC Biotechnol 12:14
Nausch H, Mikschofsky H, Koslowski R, Meyer U, Broer I, Huckauf J (2012) High level transient expression of ER-targeted human interleukin-6 in Nicotiana benthamiana. PLoS One 7:e48938
Nykiforuk CL, Shen Y, Murray EW, Boothe JG, Busseuil D, Rheaume E, Tardif JC, Reid A, Moloney MM (2011) Expression and recovery of biologically active recombinant apolipoprotein AI (Milano) from transgenic safflower (Carthamus tinctorius) seeds. Plant Biotechnol J 9:250–263
Obembe OO, Popoola JO, Leelavathi S, Reddy SV (2011) Advances in plant molecular farming. Biotechnol Adv 29:210–222
Park S, Yi N, Kim YS, Jeong M, Bang S, Choi YD, Kim J (2010) Analysis of five novel putative constitutive gene promoters in transgenic rice plants. J Exp Bot 61:2459–2467
Paul M (2015) International society for plant molecular farming. Transgenic Res 24:375–380
Paul M, Ma JKC (2011) Plant-made pharmaceuticals: leading products and production platforms. Biotechnol Appl Biochem 58:58–67
Penney CA, Thomas DR, Deen SS, Amanda M, Walmsley M (2011) Plant-made vaccines in support of the millennium development goals. Plant Cell Rep 30:789–798
Peyret H, Lomonosoff GP (2013) The pEAQ vector series: the easy and quick way to produce recombinant proteins in plants. Plant Mol Biol 83:51–58
Piron R, Koker SD, De Paepe A, Goossens J, Grooten J, Nauwynck H, Depicker A (2014) Boosting in Planta production of antigens derived from the porcine reproductive and respiratory syndrome virus (PRRSV) and subsequent evaluation of their immunogenicity. PLoS One 9:e91386
Platis D, Labrou NE (2009) Application of a PEG/salt aqueous two-phase partition system for the recovery of monoclonal antibodies from unclarified transgenic tobacco extract. Biotechnol J 4:1320–1327
Rigano MM, Scotti N, Cardi T (2012) Unsolved problems in plastid transformation. Bioengineered 3:329–333
Sabalza M, Christou P, Capell T (2014) Recombinant plant-derived pharmaceutical proteins: current technical and economic bottlenecks. Biotechnol Lett 36:2367–2379
Sack M, Hofbauer A, Fischer R, Stoger E (2015) The increasing value of plant made proteins. Curr Opin Biotechnol 32:163–170
Scotti N, Cardi T (2014) Transgene-induced pleiotropic effects in transplastomic plants. Biotechnol Lett 36:229–239
Shanmugaraj BM, Ramalingam S (2014) Plant expression platform for the production of recombinant pharmaceutical proteins. Austin J Biotechnol Bioeng 1:4
Shchelkunov SN, Salyaev RK, Pozdnyakov SG, Rekoslavskaya NI, Nesterov AE, Ryzhova TS, Sumtsova VM, Pakova NV, Mishutina UO, Kopytina TV, Hammond RW (2006) Immunogenicity of a novel, bivalent, plant-based oral vaccine against hepatitis B and human immunodeficiency viruses. Biotechnol Lett 28:959–967
Shoseyov O, Posen Y, Grynspan F (2014) Human collagen produced in plants: more than just another molecule. Bioengineered 5:49–52
Sindarovska YR, Gerasymenko IM, Sheludko YV, Olevinskaya ZM, Spivak NY, Kuchuk NV (2010) Production of human interferon alpha 2b in plants of Nicotiana excelsior by Agrobacterium-mediated transient expression. Cytol Genet 44:313–316
Sparrow P, Broer I, Hood EE, Eversole K, Hartung F, Schiemann J (2013) Risk Assessment and regulation of molecular farming—a comparison between Europe and US. Curr Pharm Des 2013:19
Stoger E, Fischer R, Moloney M, Ma JKC (2014) Plant molecular pharming for the treatment of chronic and infectious diseases. Ann Rev Plant Biol 65:743–768
Sully EK, Whaley KJ, Bohorova N, Bohorov O, Goodman C, Kim Do H, Pauly MH, Velasco J, Hiatt E, Morton J, Swope K, Roy CJ, Zeitlin L, Mantis NJ (2014) A chimeric plantibody passively protects mice against aerosolized ricin challenge. Clin Vaccine Immunol 21:777–782
Thomas DR, Walmsley AM (2014) Improved expression of recombinant plant-made hEGF. Plant Cell Rep 33:1801–1814
Thomas DR, Penney CA, Majumder A, Walmsley AM (2011) Evolution of plant-made pharmaceuticals. Int J Mol Sci 12:3220–3236
Tusé D, Tu T, McDonald KA (2014) Manufacturing economics of plant-made biologics: case studies in therapeutic and industrial enzymes. Biomed Res Int (article ID 256135)
Vardakoua M, Sainsburyb F, Rigby N, Mulhollanda F, Lomonossoff GP (2012) Expression of active recombinant human gastric lipase in Nicotiana benthamiana using the CPMV-HT transient expression system. Protein Expr Purif 81:69–74
Veale MA, Slabbert MM, Van Emmenes L (2012) Agrobacterium-mediated transformation of potato cv. Mnandi for resistance to the potato tuber moth (Phthorimaea operculella). S Afr J Bot 80:67–74
Webster DE, Thomas MC (2012) Post-translational modification of plant made foreign proteins; glycosylation and beyond. Biotechnol Adv 30:410–418
Werner S, Breus O, Symonenko Y, Marillonnet S, Gleba Y (2011) High-level recombinant protein expression in transgenic plants by using a double-inducible viral vector. Proc Natl Acad Sci USA 108:14061–14066
Wilken LR, Nikolov ZL (2012) Recovery and purification of plant-made recombinant proteins. Biotechnol Adv 30:419–433
Xu C, Li L, Jin W, Wan Y (2014) Recombinase polymerase amplification (RPA) of CaMV 35S promoter and nos terminator for rapid detection of genetically modified crops. Int J Mol Sci 15:18197–18205
Yemets AI, Tanasienko IV, Krasylenko YA, Blume YB (2014) Plant-based biopharming of recombinant human lactoferrin. Cell Biol Int 38:989–1002
Yusibov V, Streatfield SJ, Kushnir N (2011) Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond. Hum Vaccines 7:313–321
Zhang D, Nandi S, Bryan P, Pettit S, Nguyen D, Santos MA, Huang N (2010) Expression, purification, and characterization of recombinant human transferrin from rice (Oryza sativa L.). Protein Expr Purif 74:69–79
Zimran A, Brill-Almon E, Chertkoff R, Petakov M, Blanco-Favela F et al (2011) Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease. Blood 118:5767–5773
Acknowledgements
The authors thank Vignan’s University, India for its in-house administrative and financial resources to execute this work. This work was supported in part by a Grant (ECR/2016/000304) from Science and Engineering Research Board, New Delhi, India under the young scientist scheme. We also thank the anonymous reviewers for their comments which helped us in improving the quality of manuscript. We thank Dr. David McMurray, Regents Professor, Texas A & M University System Health Science Center, College Station, USA for providing valuable comments.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by A. K. Kononowicz.
Rights and permissions
About this article
Cite this article
Dirisala, V.R., Nair, R.R., Srirama, K. et al. Recombinant pharmaceutical protein production in plants: unraveling the therapeutic potential of molecular pharming. Acta Physiol Plant 39, 18 (2017). https://doi.org/10.1007/s11738-016-2315-3
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11738-016-2315-3